Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
Gate MCP
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 30+ AI models, with 0% extra fees
Sun Pharma launches India’s largest outbound pharma deal with Organon
📌 Sun Pharma announced an all-cash agreement to acquire Organon for $11.75 billion, or $14 per share, marking a major international move for India’s pharmaceutical sector.
💊 Organon was spun off from Merck in 2021 and owns more than 70 products across around 140 countries, with exposure to women’s health, general medicines, and biosimilars.
📈 After the deal, Sun Pharma is expected to reach around $12.4 billion in combined revenue, enter the top 25 global pharmaceutical companies, and lift innovative medicines to 27% of total revenue.
⚠️ The short-term market reaction has been positive, with Sun Pharma shares rising sharply, but investors still need to watch debt pressure, integration costs, and regulatory approvals before the deal’s expected closing in early 2027.
#Pharma #MarketInsights